Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Centro de Estudios en Cardiología Intervencionista (CECI) is a specialized clinical research organization and educational center based in Buenos Aires, Argentina, focusing on interventional cardiology and vascular medicine. Founded by the late Dr. Liliana Grinfeld, a pioneer in the field, the center serves as a high-volume site for international multicenter clinical trials ranging from Phase 2 to Phase 4. CECI is particularly recognized for its expertise in evaluating cardiovascular medical devices, such as drug-eluting stents and transcatheter heart valves, as well as novel antithrombotic pharmacotherapies. The institution provides comprehensive clinical research services, including patient recruitment, trial management, and regulatory compliance. Beyond research, CECI is a key hub for advanced fellowship training and continuing medical education for cardiologists across Latin America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centro de Estudios en Cardiología Intervencionista.